Ovarian cancer, often diagnosed late due to subtle symptoms, sees significantly improved survival rates with early detection.

Facility-level disparities in adopting minimally invasive interval debulking surgery for ovarian cancer highlight urgent ...

A panelist discusses how antibody-drug conjugates like mirvetuximab should be sequenced in platinum-resistant ovarian cancer, ...

Ovarian cancer is often called the “silent killer” because it’s notoriously difficult to detect in its early stages Our ...

Canada is among countries that have made it a goal to eliminate cervical cancer by or before 2040. Some countries — notably ...

Ovarian cancer, often termed a silent killer, remains underdiagnosed due to vague symptoms and lack of screening. With high ...

Ovarian cancer’s lack of early symptoms makes it a difficult disease to catch in its initial stages, but by understanding the ...

The seventh warning indicator of poor ovary health or ovarian cancer is a visible change in the bowel movement. Studies have ...

In the phase 2/3 REFRαME-O1 trial, luveltamab tazevibulin showed encouraging responses in patients with ovarian cancer with ...

The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade ...

The new National Cancer Plan offers a real chance to close survival gaps by making early diagnosis and fair access to ...